These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20939666)

  • 21. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R; Nichols DE
    Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia.
    Jaehne EJ; Salem A; Irvine RJ
    Psychopharmacology (Berl); 2007 Sep; 194(1):41-52. PubMed ID: 17530474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.
    Fantegrossi WE; Bauzo RM; Manvich DM; Morales JC; Votaw JR; Goodman MM; Howell LL
    Psychopharmacology (Berl); 2009 Aug; 205(2):337-47. PubMed ID: 19421742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.
    Gold LH; Koob GF; Geyer MA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):547-55. PubMed ID: 2903234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of (+)-methamphetamine, ±-methylenedioxymethamphetamine, (+)-amphetamine and ±-fenfluramine in rats on egocentric learning in the Cincinnati water maze.
    Vorhees CV; He E; Skelton MR; Graham DL; Schaefer TL; Grace CE; Braun AA; Amos-Kroohs R; Williams MT
    Synapse; 2011 May; 65(5):368-78. PubMed ID: 20730798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
    Yarosh HL; Katz EB; Coop A; Fantegrossi WE
    Pharmacol Biochem Behav; 2007 Nov; 88(1):18-27. PubMed ID: 17651790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze.
    Navarro JF; Maldonado E
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1151-4. PubMed ID: 12452538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of spontaneous behavior following acute MDMA treatment in male and female rats.
    Pálenícek T; Hlinák Z; Bubeníková-Valesová V; Votava M; Horácek J
    Neuro Endocrinol Lett; 2007 Dec; 28(6):781-8. PubMed ID: 18063949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Allott K; Redman J
    Neurosci Biobehav Rev; 2007; 31(3):327-47. PubMed ID: 17109962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA).
    Young R; Khorana N; Bondareva T; Glennon RA
    Pharmacol Biochem Behav; 2005 Oct; 82(2):404-10. PubMed ID: 16253319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human Pharmacology of Mephedrone in Comparison with MDMA.
    Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
    Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiogenic-like activity of 3,4-methylenedioxy-methamphetamine ("Ecstasy") in the social interaction test is accompanied by an increase of c-fos expression in mice amygdala.
    Navarro JF; Rivera A; Maldonado E; Cavas M; de la Calle A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):249-54. PubMed ID: 14751419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemistry and pharmacology of hallucinogens, entactogens and stimulants.
    Kovar KA
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine.
    Zacny JP; Virus RM; Woolverton WL
    Pharmacol Biochem Behav; 1990 Mar; 35(3):637-42. PubMed ID: 1971112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats.
    Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ
    Neurosci Lett; 2002 Sep; 330(3):280-4. PubMed ID: 12270646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.
    Skelton MR; Schaefer TL; Herring NR; Grace CE; Vorhees CV; Williams MT
    Psychopharmacology (Berl); 2009 Jun; 204(2):287-97. PubMed ID: 19198809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration.
    Reveron ME; Maier EY; Duvauchelle CL
    Behav Brain Res; 2010 Mar; 207(2):500-7. PubMed ID: 19891989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.
    Morley KC; McGregor IS
    Eur J Pharmacol; 2000 Nov; 408(1):41-9. PubMed ID: 11070182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.